Chipotle Mexican Grill, Inc. · CMG

HOLD with a $42 base price target (+15.0%) and $39.90 probability-weighted target (+9.3%) over 12 months.

CMG is a high-quality restaurant compounder, but not a cheap one. The company has TTM revenue of $12.42B, TTM net income of $1.42B, TTM free cash flow of $1.57B, and a 3.4% FCF yield at the current market cap. Q2 2026 was operationally encouraging: revenue grew 9.3%, comps rose 2.2%, transactions turned positive, and management raised full-year comparable-sales guidance to low single digits.

The offset is valuation and current headline risk. At roughly 27.9x forward earnings and about 29.3x free cash flow, the stock already assumes a meaningful recovery in traffic and margins. The recent jalapeño/salmonella supply-chain issue appears potentially containable based on public company statements, but food-safety headlines are uniquely important for Chipotle because brand trust is the moat.

The right posture is to hold core quality exposure, add only on pullbacks, and avoid chasing the rebound until Q3 traffic confirms that the food-safety and consumer-slowdown impact is short-lived.

Key Metrics:

Recent performance: TTM revenue is $12.42B versus FY2025 revenue of $11.93B and FY2024 revenue of $11.31B. TTM revenue growth of 7.3% is respectable, but below the historical growth rate investors once capitalized at much higher multiples. TTM operating margin is 15.27%, down from FY2025's 16.94% and FY2024's 17.33%, showing that cost inflation and traffic softness are real.

Q2 2026 operating read: Revenue increased 9.3% to $3.35B; comparable restaurant sales increased 2.2%, consisting of +1.2% average check and +1.0% transactions. Digital sales were 38.3% of food and beverage revenue, supporting the digital/Rewards part of the thesis. Restaurant-level operating margin was 25.2%, down from 27.4% last year, with food, beef/freight, labor, and other operating costs pressuring profitability.

Cost structure: Food, beverage, and packaging costs were 29.7% of Q2 revenue, up 80 bps YoY; labor was 25.0%, up 30 bps YoY; G&A was $190.5M, up from $172.2M. Management cited inflation, beef, freight, higher protein/produce usage, wage inflation, bonuses, hospitality investments, legal reserves, and restructuring costs.

Forward outlook: Management raised full-year 2026 comparable-sales guidance to low single digits and expects 350-370 openings, including 10-15 international partner-operated restaurants and roughly 80% of new company-owned restaurants with Chipotlanes. The fundamental debate is whether positive transaction comps can continue while margins recover enough to justify the premium multiple.

The balance sheet is acceptable for a profitable, cash-generative restaurant chain, but it is not a fortress in the same way as a net-cash software or semiconductor compounder. The reported net debt of $4.74B is largely lease-related, and lease obligations are intrinsic to the restaurant growth model.

Cash generation is the key support. TTM operating cash flow is $2.33B, capex is $758.5M, and free cash flow is $1.57B. The company used $1.35B for repurchases in the first half of 2026, including $630.7M in Q2 at an average price of $32.55. That buyback is accretive if the business continues compounding, but it becomes less attractive if traffic weakens or legal/food-safety costs rise.

Near-term catalysts:

Medium-term catalysts:

Event-driven: Food-safety resolution, additional public-health disclosures, or evidence of supplier containment can move CMG sharply because the brand has a long investor memory around foodborne illness risk.

Consensus context: StockAnalysis shows an average analyst target of $43.80 from 34 analysts, while Finviz shows $44.08. The report's base target of $42 is below consensus because the current setup still requires evidence that traffic and margins are recovering after food-safety and consumer-pressure headlines.

PT-revision velocity: Mixed. The last 90 days include upgrades from JP Morgan, Argus, and Mizuho, but also a Morgan Stanley downgrade to Equal-Weight. This is not a clean upward-revision cluster; the market is debating recovery versus premium valuation.

Probability-weighted target: $39.90, calculated as 25% × $52 + 45% × $42 + 25% × $28 + 5% × $20.

Multiple decomposition:

Sensitivity: At base EPS of $1.50, every 1x change in the P/E multiple equals about $1.50 per share, or 4.1% of the current stock price. The valuation is therefore highly sensitive to whether investors view CMG as a 30x compounding story or a 23-25x mature restaurant story.

Multi-horizon checkpoints:

Red-flag pattern count: 2/8.

Asymmetry verdict: Balanced but not compelling enough for a fresh BUY at $36.51. CMG has high-quality upside if comps and margins recover, but the base-to-probability-weighted upside is modest and the valuation leaves limited room for food-safety, traffic, or margin disappointment. Hold existing core exposure; add only when price or evidence improves.

Ranked risks:

1. Food-safety and brand trust: The August 2026 jalapeño/salmonella supply-chain issue may prove contained, but any restaurant chain tied to foodborne illness headlines can see fast traffic and multiple compression.
2. Premium valuation: At roughly 27.9x forward earnings and 29.3x FCF, the stock has limited tolerance for slow comps or margin disappointment.
3. Traffic and consumer pressure: Q2 transactions turned positive, but 2025 comps were soft and value perception remains a risk in a stretched consumer environment.
4. Margin pressure: Beef, freight, labor, hospitality staffing, legal reserves, and pre-opening costs can absorb the benefit of price and volume.
5. Unit-growth execution: The model depends on high-return new units and Chipotlane productivity; site quality and construction execution matter as the base grows.
6. Lease leverage: Reported debt is mostly lease obligations, but leases are fixed claims on future restaurant cash flow.
7. International execution: Partner-operated markets add optionality but also brand-control and execution risk.

Sizing guidance: CMG is appropriate as a quality core/satellite consumer position, not a deep-value position. Core holders can maintain exposure, but new capital should be staged. Avoid increasing size above normal weight until Q3 confirms that traffic remains resilient after the food-safety headlines.

Velocity flag: Neutral. RSI is below 75 and price is not more than 30% above the 200-day SMA, so there is no automatic satellite-trim signal. It is also not an undershoot because RSI is not below 30 and price is not below 85% of the 200-day SMA.

Technically, the stock has repaired some damage after the early-August selloff. The setup is constructive above the 200-day SMA, but the $42-44 area is a natural resistance/valuation zone unless Q3 traffic and EPS revisions improve.

Insider ownership is not the reason to own CMG. The stronger shareholder signal is the buyback: shares outstanding decreased materially over the last year, and the company had $1.7B remaining authorization after Q2 2026. That said, high institutional ownership creates crowding risk: if comps or food-safety headlines disappoint, the stock can de-rate quickly because the holder base is valuation-sensitive.

Recent news flow is mixed-to-positive operationally but complicated by food-safety headlines.

Positive: Q2 2026 beat expectations on revenue and earnings, comparable sales improved to +2.2%, transactions turned positive, management raised full-year comparable-sales guidance, and the company continued aggressive buybacks. International expansion also advanced with Mexico and Saudi Arabia openings through partner-operated models.

Negative / watch item: August 2026 headlines linked jalapeños from a supplier lot to a salmonella investigation affecting Mexican-style quick-service restaurants. Chipotle said it identified a common ingredient lot, removed the relevant jalapeños from affected restaurants, replaced them with other supply, and stated that public-health agencies did not view there as being a current ongoing risk from Chipotle restaurants after those actions. Even if contained, this is a sentiment overhang because food safety is a central brand-risk variable.

No independent numerical sentiment score was available; this is a qualitative read.

Governance read: Management and board quality are above average, but not yet through-cycle proven under the current leadership configuration. Scott Boatwright is a credible operations-oriented CEO, Adam Rymer is a recently appointed CFO, Jason Kidd is a recently appointed COO, and the board moved quickly to stabilize leadership after the prior CEO transition.

Weighted governance pillars:

Weighted average is 3.75/5, producing a B rating. The key governance question is not whether Chipotle has formal structures; it does. The question is whether this board and refreshed management team can restore margin and traffic momentum without allowing food-safety, labor, or legal risk to undermine brand trust.

Buzzword-washing score: 3/10

CMG is not a story-stock pivot. It has real revenue, cash flow, store growth, and unit economics. The narrative risk is more subtle: investors may overcapitalize the brand and unit-growth story at a time when comps, margins, and food-safety sentiment still need confirmation.

Dilution-to-progress ratio: favorable. Revenue rose from $7.55B in FY2021 to $12.42B TTM, while shares outstanding declined from roughly 1.40B to about 1.27B. Revenue growth and buybacks both improved per-share economics.

The main caveat is price discipline. Repurchases are clearly reducing share count, but buybacks at high valuation multiples are only superior to cash retention if the company sustains high incremental returns on new units and avoids a durable traffic or margin reset.

CMG's revenue quality is strong for a restaurant company because the model is simple, cash-generative, and overwhelmingly based on food and beverage sales from company-operated restaurants. Delivery service revenue is small, and the company has limited receivables relative to revenue.

The quality grade is B+. The revenue base is real and cash-converting, but restaurant revenue is inherently less durable than contracted recurring revenue and can be disrupted quickly by health, brand, or value-perception headlines.